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the vertical orientation of collagen fibers. The biomineralized layer shows a highly 
fibrous structure with well interconnected pores with diameters up to 600 micron. 
Chemical characterization was performed to verify the composition and quantify 
the percentage of the inorganic mineral content. 
The biomaterial was shaped in disks of 2.5cm of diameter and appeared to be 
suitable for culture of nasal chondrocytes for 5 weeks in perfusion bioreactor. Pre-
liminary experiments showed the potential of the engineered graft for mimimally 
invasive treatment of osteochondral lesions. 
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Nasal chondrocytes could be viable alternative for ACI in human patients. Befo-
re using it in clinical settings, it is necessary to test this hypothesis on translational 
(large animal) model. 
Designed model was chronic, full-thickness cartilage defect placed on lateral 
and medial femoral condyles in sheep. The protocol included two surgical procedu-
res. First procedure was to create two partial-thickness defects, 4 mm in diameter on 
the lateral and medial femoral condyle with a standard mosaicplasty instruments 
used in human orthopaedic surgery. Biopsy of nasal septum cartilage was also per-
formed with skin biopsy puncher, 8 mm in diameter. Cartilage samples from both 
origins were used for production of autologous tissue grafts. Chondrocytes were 
isolated, seeded on biphasic collagen-hydroxiapatite scaffolds, and cultured in au-
tomated bioreactor for 5 weeks. Engineered tissue was then implanted in condyle 
defects during second procedure. First, 4 mm partial-thickness defects were conver-
ted to osteochondral defects 6,5 mm in diameter and 5 mm deep. Then engineered 
cartilage tissue was implanted. There were four study groups. Autologous tissue 
grafts, engineered from scaffold and nasal septum chondrocytes were implanted 
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in the experimental group of animals. One group was implanted with autologous 
tissue grafts engineered from scaffold and articular chondrocytes. In one group cell 
free scaffolds were implanted while last group served as negative control in which 
only conversion of defect was performed, but it was left untreated. Animals were 
sacrificed and tissue analysis was performed at three different time points: 6 weeks, 
3 months and 12 months after the implantation. Tissue analysis included macrosco-
pic, microscopic and molecular evaluation. Microscopic analysis included different 
stains (hematoxylin-eosin, safranin O, picrosirius) and immunohistochemistry (co-
llagen I, II and aggrecan). Semi-quantitative data of morphology were obtained with 
histological score ICRS II. ELISA and DMMB assays were performed to quantify the 
amount of collagen I, II and glycosaminoglycans in repair tissue. 
Results confirmed the feasibility of production of autologous cartilage tissue 
grafts from nasal septum chondrocyte for treatment of condyle cartilage defects. 
Furthermore, nasal chondrocyte grafts showed promising results in restoration of 
damaged articular cartilage. 
The research leading to these results has received funding from the Europe-
an Union’s Seventh Framework Programme (FP7/2007-2013) under grant agreement 
n°278807 BIO-COMET. 
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Purpose 
As compared to commonly used cell based treatments for articular cartilage repair, 
grafting of cartilage tissues, engineered in vitro to reach a mature stage, could result 
in more durable repair. To reduce the variability in the quality of the engineered tissue 
grafts, nasal chondrocytes were used as a cell source with reproducible chondrogenic 
capacity. The purpose of this phase-1 study was to demonstrate safety and feasibility of 
the procedure. Preliminary indications on efficacy after 12 months are also presented. 
Material and methods 
Ten patients with symptomatic, post-traumatic full-thickness cartilage lesions 
(2-8cm2) on the femoral condyle/ trochlea were treated. Patients underwent nasal 
Rad za med znan 43 - book 1.indb   62 2.6.2016.   11:45:04
